Related Experiment Video

Updated: Apr 30, 2026

Forward Genetic Approaches in Chlamydia trachomatis
09:03

Forward Genetic Approaches in Chlamydia trachomatis

Published on: October 24, 2013

12.4K

Pathogenetic mechanisms and epidemiology of Chlamydia pneumoniae

M Leinonen1

  • 1Department of Respiratory Bacterial Infections, National Public Health Institute, Helsinki, Finland.

European Heart Journal
|December 1, 1993
PubMed

Insights

Chlamydia pneumoniae infections are common globally, particularly in older males, and can lead to chronic inflammation and long-term health issues. Early childhood or teenage exposure can result in severe sequelae decades later.

Area of Science:

  • Infectious Diseases
  • Immunology
  • Cardiovascular Health

Background:

  • Chlamydia pneumoniae infections are prevalent worldwide, with varying age of acquisition based on geographic location.
  • Infections are more common in middle-aged and elderly males compared to females.
  • Chlamydial species are known to cause chronic infections with delayed severe sequelae.

Purpose of the Study:

  • To investigate the prevalence and long-term implications of Chlamydia pneumoniae infections.
  • To understand the mechanisms by which chronic C. pneumoniae infections may contribute to vascular disease.

Main Methods:

  • Analysis of antibody prevalence data to determine infection patterns.
  • Review of existing literature on chlamydial infections and their chronic effects.

Main Results:

  • C. pneumoniae infections are widespread, with acquisition typically occurring in childhood in populated areas and later in northern countries.
  • Severe health consequences can manifest 10 to 50 years post-infection.
  • Chronic infections may involve C. pneumoniae residing in macrophages and endothelial cells, facilitating bacterial access to circulation.

Conclusions:

  • Chronic C. pneumoniae infections can lead to persistent cytokine induction.
  • Continuous inflammation of vascular endothelium is a potential outcome of chronic C. pneumoniae presence.
  • Understanding these infection dynamics is crucial for managing long-term health risks.

More Related Videos

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria11:32

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria

Published on: February 23, 2014

14.6K
A Mouse Model for the Transition of Streptococcus pneumoniae from Colonizer to Pathogen upon Viral Co-Infection Recapitulates Age-Exacerbated Illness12:21

A Mouse Model for the Transition of Streptococcus pneumoniae from Colonizer to Pathogen upon Viral Co-Infection Recapitulates Age-Exacerbated Illness

Published on: September 28, 2022

3.9K

Related Concept Videos

Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
1.5K
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
4.7K
Bacterial Phylum Chlamydiae01:29

Bacterial Phylum Chlamydiae

The phylum Chlamydiae or Chlamydiota is composed of a single order, Chlamydiales. This phylum consists entirely of obligate intracellular parasites that infect eukaryotic hosts. While human pathogens within this group have been studied extensively, the phylum encompasses many species capable of interacting with various eukaryotic organisms. Members of Chlamydiae are typically small cocci, approximately 0.5 μm in diameter, and exhibit a distinctive developmental cycle. As is characteristic...
842
Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease...
84
Chronic Obstructive Pulmonary Disease I: Introduction01:23

Chronic Obstructive Pulmonary Disease I: Introduction

Chronic obstructive pulmonary disease is a common, preventable, and treatable respiratory disorder characterized by persistent symptoms and progressive airflow limitation. This limitation results from a combination of small-airway disease (obstructive bronchiolitis) and parenchymal destruction (emphysema), both driven by chronic inflammation from exposure to harmful particles or gases.The disease includes two main pathological entities: emphysema, marked by destruction of alveolar walls and...
33
Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...
24